Contact us

Whether you’re a customer, a job seeker, a health professional or an investor, the best way to contact our Belgian offices you can find below.

Error loading Partial View script (file: ~/Views/MacroPartials/InlineImage.cshtml)

GlaxoSmithKline Pharmaceuticals SA/NV

Site Apollo
Avenue Pascal, 2-4-6
1300 Wavre
Tel :+ 32 10 85 85 00

 

Error loading Partial View script (file: ~/Views/MacroPartials/InlineImage.cshtml)

GlaxoSmithKline Biologicals SA (Vaccines)

Error loading Partial View script (file: ~/Views/MacroPartials/InlineImage.cshtml) Error loading Partial View script (file: ~/Views/MacroPartials/InlineImage.cshtml)

GlaxoSmithKline Consumer Healthcare SA

Site Apollo
Avenue Pascal, 2-4-6
1300 Wavre
Tel :+32 10 85 86 00

More information on our location.

Privacy contact information

On this page you will find contact details for GSK companies in the European Economic Area (EEA) and Switzerland, each of which acts as data controller.

If you wish to contact the GSK Data Protection Officer or contact one of the GSK companies listed, please use the contact details provided on the page.

Our Privacy Notice outlines how GSK handles the processing of personal information when dealing with your enquiry, complaint or adverse event report. You can consult this notice that was given to you when your personal information was collected by clicking on this hyperlink.

Report an adverse event

For Belgium: Please report adverse events to the Belgian Centre for Pharmacovigilance for medicines for Human use (BCPH) of the Federal Agency for Medicines and Health Products (FAMHP) by following the procedure described on the website http://www.fagg-afmps.be or to GlaxoSmithKline Pharmaceuticals SA/NV at the number +32 (0)10 85 85 00.

For Luxembourg: Please report adverse events to Ministère de la Santé du Grand-Duché de Luxembourg (Division de la Pharmacie et des Médicaments at fax number +35 (0)2 24795615 or by post) or to Centre Régional de Pharmacovigilance de Lorraine (fax number +33 (0)3 83 32 33 44 or crpv@chu-nancy.fr) or to GlaxoSmithKline Pharmaceuticals SA/NV at number +32 (0)10 85 85 00.